Flagship Pioneering’s Post

Breaking news from New York, USA! 📡 Qure.ai announces strategic #investment by Merck Global Health Innovation Fund to boost innovation of #healthcareAI. Read full story here - https://lnkd.in/dtAk3VdG David M.Rubin, Managing Director, Merck Global Health Innovation Fund LLC states: “Initial real-world studies and recent FDA clearances have provided compelling evidence for the potential of Qure.ai’s medical imaging AI innovations. AI has the potential to power the early diagnosis of #lungcancer, #TB or #Stroke giving the best chance of survival outcomes and improving quality of life for patients.” The funding will go towards investing into foundation models for #artificialintelligence in #imaging and expanding geographical reach of Qure.ai’s AI-powered imaging solutions into the US market.

⚕️ Don’t miss QIAGEN at the AI and Data in Pharma Healthcare Summit in Munich, Germany! Learn how you can leverage our unique blend of expert-curated and generative AI-derived biomedical knowledge, which lets you hit the ground running with drug discovery. Learn more 👇 #BiomedicalKB #DoYouAI

As a founder, one might have a breakthrough idea, but it is not just about an idea to get a startup going. The founder or the founding team needs necessary operational hands to navigate through the early stages of setting up the company, prepare the investor pitch deck, hire a team, getting the pro-forma financials ready, and lots of other mundane tasks to make the company INVEST-READY. And these are all outside of the core product development work! It is the meticulous planning and execution in this stage that sets the new company up for launch and fly towards growth and scale. Are you a founder or part of a team looking to support your startup journey in the initial stage? DM me and let's discuss how we can collaborate and support.

The latest issue of The High Tech Agenda is now available! In our June 2024 edition, you'll find: ✅ Details about our new whitepaper on the potential impact of artificial intelligence on Massachusetts' healthcare and life sciences sectors, a collaborative effort with Boston Consulting Group (BCG) and an advisory council of industry, hospital, and academic leaders. ✅ Information on updated MassVision2050 data and analyses covering market size, talent requirements, and growth opportunities in eight key sectors vital to Massachusetts' future success, developed with Knowledge Partner McKinsey & Company. ✅ An exciting update about High Tech Council partner STEMatch, which is actively seeking employer partners for its innovative COMPETE program. ✅ Insights from a new MassCPAs report that sheds light on the worrying trend of outmigration from Massachusetts. ✅ And more! Access all the information in the June 2024 High Tech Agenda here: https://lnkd.in/ek9aie5W

Gen AI has taken life sciences by storm, but what can really help you in your business, and what is hype? KPMG is at the heart of squashing the hype and focusing on serving our clients new, practical offerings. Check out our work in the value chain across discovery research, preclinical development, clinical trials and commercialization and our latest impact paper on Gen AI’s impact on patient care 🧬 #KPMGPrecisionMedicine #lifesciences #GenAI #KPMGHCLS

Gen AI has taken life sciences by storm, but what can really help you in your business, and what is hype? KPMG is at the heart of squashing the hype and focusing on serving our clients new, practical offerings. Check out our work in the value chain across discovery research, preclinical development, clinical trials and commercialization and our latest impact paper on Gen AI’s impact on patient care 🧬 #KPMGPrecisionMedicine #lifesciences #GenAI #KPMGHCLS

👋 Hope to see you at Vitalis in May. I will give a talk on AI and share detailed insights into the most interesting early-stage life science projects in the Nordic region and how AI connects life science and technology. These early stage companies, together with the existing ecosystem, will play a significant role in shaping the future of healthcare. A clear trend is that the boundaries between pharmaceuticals, medical technology, and e-health are gradually fading. Two particularly interesting additions to the matrix are AI and advanced materials, which, when combined, create impressive technological leaps. Pin Tuesday May 14, 2024 14:30 in your cal 😊 Scale Up Life Science Invest, magnus klaesson, Ann-Charlotte Beckman, Nasim Bergman Farrokhnia, Gunilla Englund, Karina Tellinger McNeil, Daniel Forslund, Boel Mörck, Mikael Hoffmann, Karin Gårdmark Östh, Björn Arvidsson

Gen AI has taken life sciences by storm, but what can really help you in your business, and what is hype? KPMG is at the heart of squashing the hype and focusing on serving our clients new, practical offerings. Check out our work in the value chain across discovery research, preclinical development, clinical trials and commercialization and our latest impact paper on Gen AI’s impact on patient care 🧬 #KPMGPrecisionMedicine #lifesciences #GenAI #KPMGHCLS

Gen AI has taken life sciences by storm, but what can really help you in your business, and what is hype? KPMG is at the heart of squashing the hype and focusing on serving our clients new, practical offerings. Check out our work in the value chain across discovery research, preclinical development, clinical trials and commercialization and our latest impact paper on Gen AI’s impact on patient care 🧬 #KPMGPrecisionMedicine #lifesciences #GenAI #KPMGHCLS

Gen AI has taken life sciences by storm, but what can really help you in your business, and what is hype? KPMG is at the heart of squashing the hype and focusing on serving our clients new, practical offerings. Check out our work in the value chain across discovery research, preclinical development, clinical trials and commercialization and our latest impact paper on Gen AI’s impact on patient care 🧬 #KPMGPrecisionMedicine #lifesciences #GenAI #KPMGHCLS